Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndromes
抗 CD47 单克隆抗体 CC-90002 治疗复发/难治性急性髓系白血病和高危骨髓增生异常综合征患者的 I 期临床研究
期刊:Annals of Hematology
影响因子:3
doi:10.1007/s00277-021-04734-2
Amer M Zeidan, Daniel J DeAngelo, Jeanne Palmer, Christopher S Seet, Martin S Tallman, Xin Wei, Heather Raymon, Priya Sriraman, Stephan Kopytek, Jan Philipp Bewersdorf, Michael R Burgess, Kristen Hege, Wendy Stock
